Denver PWM’s Biogen BIIB Stock Holding History

Denver PWM’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-538	Closed	-$82.3K	–	84
2024 Q4	$82.3K	Buy	538 +163	+43%	+$27.5K	0.03%	81
2024 Q3	$72.7K	Sell	375 -13	-3%	-$2.72K	0.03%	95
2024 Q2	$89.9K	Buy	+388	New	+$84.3K	0.04%	92
2023 Q2	–	Sell	-660	Closed	-$207K	–	98
2023 Q1	$207K	Buy	+660	New	+$183K	0.09%	90

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Denver PWM's BIIB Position: Q1 2025 in Review

Denver PWM sold out of Biogen (BIIB) in Q1 2025, closing a stake of 538 shares — an estimated $82.3K sold.

Denver PWM first reported a position in BIIB in Q1 2023 and held it in 4 quarters. The position peaked at $207K in Q1 2023. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Denver PWM reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
Denver PWM sold 538 Biogen shares in Q1 2025, an estimated $82.3K.
Denver PWM first reported a position in Biogen in Q1 2023 and held it in 4 quarters.
Denver PWM's Biogen position peaked at $207K in Q1 2023.
883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Denver PWM's 13F filing for Q1 2025, filed 7 May 2025.